Who are we?

Radiotarget started its activities as a startup whose main objective is the Research and Development of new diagnostic and therapeutic radiopharmaceuticals, with the aim of being a pioneer in the production of radiopharmaceuticals in Brazil. In the pipeline of the startup are radiopharmaceuticals (aptamers, peptides, and small molecules) aimed at the diagnosis of tumors, inflammatory diseases and the central nervous system by molecular imaging with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). In addition, Radiotarget has applied efforts in the development of therapeutic radiopharmaceuticals using beta radionuclides and alpha emitters.

RESEARCH AND DEVELOPMENT
Research and Development of new diagnostic and therapeutic radiopharmaceuticals
RADIOPHARMACEUTICALS PRODUCTION

PRODUCTION OF DIAGNOSTIC AND THERAPEUTIC RADIOPHARMACEUTICALS

RESOURCES PLANNING

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cur tantas regiones barbarorum pedibus obiit, tot maria transmisit.

CONFLICT MANAGEMENT
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cur tantas regiones barbarorum pedibus obiit, tot maria transmisit.
LEADERSHIP TRAINING

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cur tantas regiones barbarorum pedibus obiit, tot maria transmisit.

EXIT PLANNING

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cur tantas regiones barbarorum pedibus obiit, tot maria transmisit.